Synthetic CBD might offer protection from COVID-19, Canadian research shows
More research saying cannabinoids might protect human cells from COVID-19 was released this week by scientists in Ontario, Canada, who work with synthetic CBD.
More research saying cannabinoids might protect human cells from COVID-19 was released this week by scientists in Ontario, Canada, who work with synthetic CBD.
The second-biggest adult-use cannabis market in Canada, the province of Quebec, is now requiring proof of vaccination for the COVID-19 virus for entry into any of its regulated marijuana stores.
Now that the new year is here, cannabis industry executives can expect to face a crosscurrent of trends in 2022.
Political and pandemic upheavals made 2020 an exceptional year.
And the roller-coast ride failed to slow in 2021, marking a second straight year of extreme unpredictability for the cannabis industry.
The business story of the holiday season – record-breaking inflation caused by supply-chain pressure – has hit the cannabis industry especially hard.
Vaccine mandates aren’t popular among cannabis employers, most of whom are too small to face government directives.
Now that the omicron variant of COVID-19 has found its way into the United States, marijuana businesses – particularly retailers – are contemplating how the shifting pandemic situation might affect their daily operations.